Wegovy and Zepbound are the two FDA-approved brand-name GLP-1 medications indicated for chronic weight management, and as of 2026 three consumer telehealth platforms have built a legitimate path to prescribing them: Hims & Hers, Ro, and LifeMD. All three route a qualifying patient’s self-pay prescription through the manufacturer’s own program — NovoCare for Wegovy, LillyDirect for Zepbound — rather than a compounding pharmacy.
This guide compares only the brand-name path through each platform. It does not cover compounded semaglutide or tirzepatide, and it does not evaluate any provider on how well its compounded product used to work, because that is not what you would be signing up for today. Noom Med is included below for context, since it is a widely searched comparison point, but GLP-1 Explained has no referral relationship with Noom and there is nothing to click through to.
This guide provides general information and is not medical advice. Talk to your prescriber or pharmacist before starting, stopping, or changing any medication, supplement, or device used alongside GLP-1 therapy.
What Each Platform Actually Includes
Hims & Hers runs an online intake questionnaire reviewed by a licensed clinician, followed by asynchronous messaging for most follow-ups rather than a scheduled video call. For patients who meet the BMI and clinical-history requirements, the prescription is written for brand-name Wegovy or Zepbound through the manufacturer partnership, not a compounded formulation — worth confirming explicitly during intake, since the same company’s consumer brand has also marketed compounded GLP-1 products in the past and received an FDA warning letter over that marketing in September 2025. See current plans at Hims & Hers. Disclosure: this is an affiliate link. GLP-1 Explained may earn a commission if you buy or sign up, at no extra cost to you. This is not medical advice.
Ro bundles the consultation, at-home or in-network lab work, and ongoing prescriber access into one membership, and it markets itself heavily on lab inclusion — useful if you do not already have recent bloodwork. Check eligibility with Ro. Ro is also a Novo Nordisk partner for brand-name Wegovy access, and states its clinicians will not prescribe a compounded product to a patient who qualifies for and wants the brand-name drug — the trade-off is a higher visible membership price for that bundling, and clinician availability that can vary by state.
LifeMD operates more like a general telehealth membership with a weight-management track layered on top, which means the same subscription can also cover primary-care and urgent-care visits if you use them. That is convenient for someone who wants one telehealth relationship rather than three, and a real drawback for someone who only wants the GLP-1 piece and does not want to pay for a broader membership to get it. Explore LifeMD’s program to see current plan tiers.
Noom Med, the clinical arm of the Noom app, pairs its behavior-change coaching with telehealth GLP-1 prescribing. It is included in the comparisons below because it is one of the most frequently searched alternatives to the three platforms above, not because GLP-1 Explained has any relationship with the company.
How Self-Pay Pricing Actually Flows Through Each Platform
None of these platforms sets the price of the medication itself. Wegovy’s self-pay cash price runs through NovoCare at a published rate of about $499 a month as of 2026, and Zepbound’s self-pay vials run through LillyDirect at roughly $349 to $499 a month depending on dose. What each platform actually charges you is a separate membership or visit fee on top of that drug cost — and that combined total, not the advertised starting price, is the number worth comparing.
Membership fees change often enough that a specific dollar figure printed here would be out of date within a quarter. The more durable comparison is structural: does the platform’s fee cover a single visit, a recurring subscription regardless of whether you are actively filling a prescription, or a bundle that includes labs and ongoing check-ins? Ask that question directly during intake, and get the total — membership plus drug cost — in writing before your first payment.
Insurance is a separate path from all three. Hims & Hers, Ro, and LifeMD are primarily self-pay businesses; none of them functions as an in-network provider that bills your insurance for the medication the way a primary-care office or endocrinology clinic would. If your plan already covers Wegovy or Zepbound with a manufacturer savings card layered on top, that route is very likely cheaper than any self-pay telehealth membership, and it is worth ruling out first.
Who Qualifies, and the Red Flag That Matters More Than Price
The FDA label for both Wegovy and Zepbound sets the same basic bar: a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition such as hypertension, type 2 diabetes, sleep apnea, or dyslipidemia. Every platform in this comparison uses some version of that threshold in its intake questionnaire, and none of them can prescribe around it — a platform that offers to get you a prescription without asking about BMI or medical history is not one to use.
The single most useful thing to check, on any of these three platforms, is whether the intake flow ever offers a compounded alternative as a faster or cheaper first option. A platform that leads with brand-name access and treats compounding as a separate, clearly labeled path (if it offers one at all) is behaving the way this comparison assumes; one that defaults you toward a compounded product during checkout is not the brand-name experience described here, regardless of what its marketing says elsewhere.
This combination is not a fit for anyone who is pregnant or breastfeeding, has a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, or has a history of pancreatitis — these are reasons a telehealth intake form should route you to a physician rather than a prescription, and a platform that does not ask about them at all is a platform to be cautious of.
What to Look For
Brand-name access stated plainly, with compounding offered (if at all) as a separate, clearly labeled option. If the checkout flow defaults you toward a compounded product before you have even seen a brand-name price, that is not the comparison this guide covers.
A total monthly cost you can get in writing before paying anything. Membership fee plus drug cost, not just the advertised starting price for either piece on its own.
Labs included or a documented path to get them. Ro leans on this as a selling point; Hims & Hers and LifeMD may ask you to submit recent results or use a local lab partner instead — ask which applies to you.
A cancellation process that does not require a phone call you cannot get through on. Read the cancellation terms during signup, not after you have decided to stop — subscription telehealth memberships are built to auto-renew.
Useful Extras Worth Owning
These cover the realistic range of what actually helps, from the one item worth buying first to the small extra that makes the rest of the list easier to use.
Most intake questionnaires ask for a recent blood pressure reading. Having your own cuff means you are not guessing or relying on a reading from months ago.
View on Amazon →Weekly weight and body-composition trends give you something concrete to bring to a telehealth check-in, rather than a memory of how clothes fit.
View on Amazon →Whichever platform and pharmacy you end up with, a proper sharps container is the first purchase that has nothing to do with which brand you chose.
View on Amazon →Keeps a NovoCare or LillyDirect shipment at a stable temperature on the trip from your door to the refrigerator, and on any trip after that.
View on Amazon →Hims & Hers vs Ro vs LifeMD vs Noom Med
| Provider | Model | Brand-Name Access | Labs | Best For |
|---|---|---|---|---|
| Hims & Hers | Async intake + messaging | Wegovy/Zepbound via NovoCare/LillyDirect (confirm at intake) | Submit your own or use a partner lab | Fastest, most self-serve intake |
| Ro | Membership with prescriber access | Wegovy via Novo Nordisk partnership | Included or coordinated | Wanting labs handled without a separate errand |
| LifeMD | General telehealth membership | Brand-name via Novo partnership | Varies by plan tier | Wanting one telehealth relationship for more than weight management |
| Noom Med (non-partner) | App-based coaching + telehealth prescribing | Varies; verify directly with Noom | Varies by plan | Readers who want coaching bundled with prescribing |
How to Actually Decide Between Them
If you want the least friction and are comfortable with mostly-asynchronous care, Hims & Hers’ intake is built for that. If you do not have recent labs and do not want a separate errand to get them, Ro’s bundled model removes that step. If you would rather have one telehealth account for weight management and everything else, LifeMD’s broader membership is the more efficient use of a single subscription.
Whichever you choose, treat the first visit as a screening conversation, not a purchase decision you have already made. Confirm the brand-name path in writing, get the total monthly cost before your first charge, and if anything about the intake feels like it is steering you toward a cheaper compounded product instead of the medication you came for, that is a reason to stop and look elsewhere.
Three Things a Provider Comparison Doesn’t Cover
Product roundups answer which one. They do not answer the questions that come up regardless of which products you choose:
- Whether insurance could cover this instead — the prior-authorization and savings-card path that can make a physician-prescribed route cheaper than any self-pay membership.
- Which drug you actually want — the difference between Wegovy and Ozempic, and why the same molecule has two names and two price tags.
- What to expect after the first dose — the side-effect timeline that has nothing to do with which platform wrote the prescription.